When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AKAO - Achaogen's ZEMDRI phase 3 study results published in the New England Journal of Medicine
Achaogen
Achaogen (NASDAQ:AKAO) announces that the New England Journal of Medicine has published the results from the Phase 3 EPIC (Evaluating Plazomicin In cUTI) study of ZEMDRI.